The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells.
Open Access
- 1 February 1991
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 10 (2), 343-348
- https://doi.org/10.1002/j.1460-2075.1991.tb07955.x
Abstract
CD44 is a polymorphic integral membrane protein which recognizes hyaluronate and whose proposed roles encompass lymphocyte activation, matrix adhesion and the attachment of lymphocytes to lymph node high endothelial venules (HEVs). Immunochemical and RNA blot data have supported the existence of two forms of CD44: a hematopoietic form expressed by cells of mesodermal origin (and by some carcinoma cell lines) and an epithelial form weakly expressed by normal epithelium but highly expressed by carcinomas. This report describes the isolation of a cDNA encoding a distinct CD44 polypeptide expressed by epithelial cells. Re‐expression of each form of CD44 in a B cell line allowed cells transfected with the hematopoietic but not the epithelial form to bind to viable rat lymph node HEV cells in primary culture.Keywords
This publication has 32 references indexed in Scilit:
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.The Journal of Experimental Medicine, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures.The Journal of Experimental Medicine, 1990
- Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptorNature, 1989
- Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types.The Journal of cell biology, 1989
- Molecular mechanisms underlying lymphocyte recirculation I. Functional, phenotypical and morphological characterization of high endothelial cells culturedin vitroEuropean Journal of Immunology, 1988
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987
- A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in manEuropean Journal of Immunology, 1986
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985
- Monoclonal antibody to a human brain‐granulocyte‐T lymphocyte antigen probably homologous to the W 3/13 antigen of the ratEuropean Journal of Immunology, 1980